Delivery Order SPE2DB25D9365-SPE2DB26FUJMC
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $22,534.56 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit (6ml). The award, issued on October 31, 2025, with an ultimate completion date of November 24, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating the contractor competed in the open market. This delivery order is...
- The Defense Logistics Agency awarded a $8,280.15 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. The delivery order, issued on October 21, 2025, with an ultimate completion date of November 12, 2025, was executed without a set-aside designation, demonstrating the vendor's competitive capability in unrestricted federal procurement....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,182.53 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of September 30, 2025, and was awarded on September 9, 2025. This award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete...
- The Defense Logistics Agency awarded a delivery order valued at $11,267.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ml. The contract, designated as delivery order 4570008681, carries a firm fixed-price structure with no set-aside designation and an ultimate completion date of December 2, 2025. This delivery order was issued under DMS Pharmaceutical Group's recently...
- The Defense Logistics Agency awarded a $5,633.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit (6ml). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The delivery order is scheduled for completion by November 18, 2025, with...
- The Defense Logistics Agency awarded a delivery order valued at $7,455.02 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit (6ml). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected to provide this pharmaceutical product with a firm fixed-price contract type. The delivery order carries an ultimate completion date of July 10, 2025, and was awarded on June 17, 2025, with no set-aside...
- The Defense Logistics Agency (DLA) awarded a $7,455.02 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of a Photrexa Cross-Linking Kit (6ml). This firm fixed-price delivery order, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, carries no set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's larger...
- The Defense Logistics Agency awarded a $3,727.51 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Photrexa Cross-Linking Kit 6ML. The award, issued on September 18, 2025, with an ultimate completion date of October 9, 2025, carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA under the...
- The Defense Logistics Agency awarded a $14,822.36 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 24, 2025. The delivery order, which must be completed by October 16, 2025, is for the supply of Photrexa Cross-Linking Kit (6ml), a specialized pharmaceutical product. This award was made without a set-aside designation, reflecting the company's competitive standing in the federal...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $11,182.53 to DMS Pharmaceutical Group Inc. for the supply of Photrexa Cross-Linking Kit (6ml). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this order at its Park Ridge facility, with an ultimate completion date of September 24, 2025. This delivery order was issued without a set-aside designation and represents one of many...
- SPE2DB25D9365Indefinite Delivery Contract
- SPE2DB25D9365-SPE2DB26FUJMCDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,040.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the procurement of a Photrexa Cross-Linking Kit (6ml). This firm fixed-price delivery order was issued on November 3, 2025, with an ultimate completion date of November 25, 2025, and carries no set-aside designation. The award was made without subcontractor involvement, with performance to occur in Park Ridge, Illinois. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent IDC, designated SPE2DR and valued at $499,999,999, was awarded on November 13, 2025, and establishes DMS Pharmaceutical Group as a regional prime vendor contractor through December 31, 2036. The PPV-G GEN V program authorizes DLA to issue delivery orders for a comprehensive range of pharmaceuticals and medical consumables to support Department of Defense military healthcare facilities globally, with DMS Pharmaceutical Group's substantial recent contracting activity demonstrating its established capability as a critical supplier within the federal pharmaceutical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.0k | 11/3/25 |